NIH Received $710M in Royalties from Drugmakers: Report; AI Insiders Warn of ‘Serious Risks’ Posed by the Tech | Business Matters Full Broadcast (June 4)

Royalty payments from drug companies to the National Institutes of Health (NIH) jumped following the COVID-19 pandemic in 2021, according to a new report from nonprofit government watchdog “OpenTheBooks.com”. It says, in 2022 and 2023, pharmaceutical and healthcare companies paid the NIH over $710 million in third-party royalties. A group of current and former employees at artificial intelligence companies OpenAI and DeepMind posted an open letter on Tuesday, they want artificial intelligence companies to be far more transparent about AI’s “serious risks”. They also want companies to and promise not to retaliate against current and former employees who voice concerns about the technology they’re building.Job openings have fallen to the lowest point in three years in another signal the U.S. economy is slowing. There were roughly 8 million jobs available in April — a second-straight month of shrinking openings.